Skip to content

Clinical trials

Phase 3 Renal Insufficiency, Chronic trials in India

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Renal Insufficiency, Chronic Phase: Phase 3 Country / region: India Clear all

31 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20072
20111
20141
20162
20173
20182
20192
20201
20214
20222
20233
20244
20252
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Recruiting8
Active, not recruiting6
Terminated6

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca6
Eli Lilly and Company3
GlaxoSmithKline3
Novartis Pharmaceuticals3
Amgen2
Bayer2
Novo Nordisk A/S2
The George Institute2
Alexion Pharmaceuticals, Inc.1
Boehringer Ingelheim1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Renal Insufficiency, Chronic31
Anemia5
Diabetes Mellitus, Type 24
Glomerulonephritis, IGA4
Kidney Diseases4
Kidney Failure, Chronic4
Cardiovascular Diseases3
Glomerulonephritis3
Heart Diseases3
Proteinuria3

Trials

Showing 1 to 25 of 31. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.